Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

Shionogi bolsters rare disease portfolio with $2bn IntraBio buyout

Shionogi's acquisition of IntraBio would expand its rare disease portfolio following the recent acquisition of ALS drug, Radicava.

Annabel Kartal Allen

News

Alector shares up after sealing $1.27bn Roche Parkinson’s disease license deal

Robert Barrie

News

Lilly deepens ties with Gate Bioscience in $870m deal expansion

Annabel Kartal Allen

News

CSL and Alentis ink $1.5bn partnership to progress antifibrotic drug

News

Pacira partners with Molteni for Exparel commercialisation

News

AstraZeneca opens new R&D centre in Cambridge, US

PremiumFeatures

GLP-1RA non-responders: tackling a hidden challenge behind the obesity epidemic

News

Scientists claim Nobel Prize for approach behind light-activated gene therapy

Analysis

Features

Magazine: Keep it cool

PremiumAnalyst Comment

EASD 2026: Tirzepatide outperforms semaglutide in real-world type 2 diabetes analysis

GlobalData Healthcare

PremiumAnalyst Comment

EASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis

GlobalData Healthcare

PremiumAnalyst Comment

EASD 2026: Orforglipron shows an efficacy edge over oral semaglutide in T2D

GlobalData Healthcare

Themes

Partner Content

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

Surging demand for injectable therapies (led by GLP‑1s) is exposing a new constraint in drug delivery: not innovation, but the ability to industrialise and manufacture devices at scale.

More themes

News

Australia starts investigation into OpenAI Medicare breach

Partner Content

How DFE Pharma supports confident continuous manufacturing decisions

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Acute-on-Chronic Liver Failure: Market View, Current and Future Competitive Landscape

$3495.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Alector shares up after sealing $1.27bn Roche Parkinson’s disease license deal

Lilly deepens ties with Gate Bioscience in $870m deal expansion

CSL and Alentis ink $1.5bn partnership to progress antifibrotic drug

Pacira partners with Molteni for Exparel commercialisation

AstraZeneca opens new R&D centre in Cambridge, US

GLP-1RA non-responders: tackling a hidden challenge behind the obesity epidemic

Scientists claim Nobel Prize for approach behind light-activated gene therapy

Magazine: Keep it cool

EASD 2026: Tirzepatide outperforms semaglutide in real-world type 2 diabetes analysis

EASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis

EASD 2026: Orforglipron shows an efficacy edge over oral semaglutide in T2D

Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Acute-on-Chronic Liver Failure: Market View, Current and Future Competitive Landscape

Gastroesophageal (GE) Junction Carcinomas: Global Clinical Trials Review, 2026

Cystic Fibrosis: Global Clinical Trials Review, 2026

Friedreich Ataxia: Global Clinical Trials Review, 2026

Bladder Cancer: Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Acute-on-Chronic Liver Failure: Market View, Current and Future Competitive Landscape

Gastroesophageal (GE) Junction Carcinomas: Global Clinical Trials Review, 2026

Cystic Fibrosis: Global Clinical Trials Review, 2026

Friedreich Ataxia: Global Clinical Trials Review, 2026

Bladder Cancer: Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing